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Abstract 
 
Change of distribution and timing of bite force after botulinum 
toxin type A injection evaluated by a computerized occlusion 
analysis system 
 
Ji Hee Song 
 
Department of Oral Medicine / Dental Science 
The Graduate School, Yonsei University 
 
(Directed by Professor Hyung Joon Ahn, D.D.S., Ph.D.) 
 
Often it has been observed that botulinum toxin type A has analgesic effects and reduces 
hyperactivity of injected muscle. However in our clinic, there are some patients who have 
unilateral chewing habits before botulinum toxin type A injection, but after injection, they 
indicate both masticatory force become similar. However, there were no study about this effect 
of botulinum toxin type A. So, we studied about relationship of botulinum toxin type A and 
distribution of masticatory force. 
The aim of this study was to determine the force distribution and pattern of mastication after 
injection of BTX-A into both masseter muscles. The hypothesis to be tested was that the 
v 
difference between right and left balance of occlusal force diminishes over time following 
BTX-A injection.  
Fifteen patients were submitted to BTX-A injection therapy for subjective masseter 
hypertrophy. A total of 25 U of BTX-A (50 U in total) was injected into two points located 
1 cm apart at the center of the lower one-third of both masseter muscles. All of the patients 
were examined using the T-Scan occlusion analysis system before and 4, 8, 12, and 24 weeks 
after BTX-A injection.  
A significant change in force balance was found between the right and left sides over time 
and the difference between the two sides decreased with the time post-injection, reaching a 
minimum at 12 weeks. Comparison of the force balance between the anterior and posterior 
occlusions revealed no significant difference at any of the time points. The occlusion and 
disclusion times (right and left sides) did not differ significantly with time since BTX-A 
injection. 
 
 
 
 
 
 
Keywords: Botulinum toxins type A, Bite force, Dental occlusion, Masseter muscle, 
Mastication, Time factors
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I. INTRODUCTION 
 
In dental field, the clinical use of botulinum toxin type A has been expanded for the past few 
years. It is used in treatment of masticatory and facial muscle spasm, severe bruxism, facial tics, 
orofacial dyskinesias, dystonias, and idiopathic hypertrophy of the masticatory muscles(Clark, 
2003). Also, it is used in the treatment of temporomandibular disorders (Freund et al., 2000), 
myofascial pain syndrome (Lang, 2002), a headache such as chronic migraine(Lovell and 
Marmura, 2010), recurrent dislocation on the TMJ, drooling and Frey’s syndrome(Bhogal et al., 
2006). When we apply botulinum toxin type A in various orofacial regions of patients, we often 
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inject into masticatory muscle such as masseter muscle and/or temporalis muscle. In case of 
botulinum toxin type A injected into masticatory muscles, according to the pharmacological 
property of botulinum toxin type A itself, it cause a temporary muscle paralysis, weakness and 
atrophy.  
Also, the control of mastication is dependent in large part on sensory feedback, which 
consists of epithelial mechanoreceptors, periodontal afferents, temporomandibular joint 
afferents and muscle afferents (Soboleva et al., 2005). Change in afferent input caused by 
injection of botulinum toxin type A into muscle can cause modify the response of the cortex, 
modify the motor neuron activity, and even initiate irrelevant muscle activity. Subsequently, 
injection of botulinum toxin type A into masticatory muscle can directly influence on 
mastication by muscle weakness and atrophy, also indirectly it can influence on mastication by 
effect on central pattern generator in brainstem through modifying the sensory feedback from 
masticatory muscle spindle (Okeson, 1993).  
Often it has been observed that botulinum toxin type A has analgesic effects and reduces 
hyperactivity of injected muscle(Fallah and Currimbhoy, 2012). However in our clinic, there 
are some patients who have unilateral chewing habits before botulinum toxin type A injection, 
but after injection, they indicate both masticatory force become similar. However, there were 
no study about this effect of botulinum toxin type A. So, we studied about relationship of 
botulinum toxin type A and distribution of masticatory f orce.  
The T-Scan occlusal analysis system is dental equipment for analyzing masticatory force.  
It was first devised in 1984 to measure occlusal force and contact time to utilize as a 
prosthodontic adjunction for the improvement of TMD and occlusal diagnoses in the treatment 
of occlusal problems. And it has been used as a measurement guide during the prosthetic 
insertion and occlusal adjustment procedures. The all informarion about occlusal force and 
3 
contact time is gathered to the recording sensor in T-Scan system (Kerstein et al., 2006). This 
information can be showed by movie of T-scan. So, T-scan have definitive diagnostic imaging 
of the force balance and function of the masticatory muscles(Montgomery et al., 2011).  
 
The aim of this study was to determine the force distribution and pattern of mastication after 
injection of BTX-A into the bilateral masseter muscles. The hypothesis to be tested was that the 
difference between right and left balance of occlusal force diminishes over time following 
BTX-A injection.
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II. Material and Methods 
  
1. Patient selection 
 
This study was approved by the institutional review board committee of Yonsei School of 
Dentistry (No. 2-2011-0024). A total of 15 pateints who conducted botulinum toxin injection 
therapy because of subjective masseter hypertrophy and T-scan examination were selected for 
this study. Subjects who had normal occlusal conditions(class I) were included in the study. 
However, subjects who had abnormal occlusal conditions such as missing tooth, severe tooth 
attrition which could affect the normal occlusion were excluded. And subjects who had dental 
treatment or had TMJ osteoarthritis, had occlusal interference during eccentric movement, and 
who had a experience injection of BTX-A in last six months and who got pregnant were also 
excluded.
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2. BTX-A injection 
 
The BTX-A used in this study was Botox (Allergan, Irvine, CA, USA); 100 U of Botox, 
obtained as a freeze-dried powder, was reconstituted to a concentration of 5 U/0.1 mL using 2 
mL of 0.9% sterile, nonpreserved saline, and used immediately after reconstitution. A total of 
25 units of BTX-A was injected into both masseter muscle bilaterally using a 1-ml syringe with 
a 29-gauge, 1/2-inch-long needle. Areas of masseter prominence on clenching were marked, 
and injected at two points at the center of the lower one-third of the masseter muscle separated 
by 1 cm. This site was chosen to avoid accidental toxin injection into the parotid gland, parotid 
duct, or facial artery. The Injection was conducted by a single person in order to reduce error 
range. (Fig. 1.)(Hu et al., 2010) 
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Figure 1. The red boxed area shows the botulinum toxin type A (BTX-A) injection site (Hu KS, 
Kim ST, Hur MS, Park JH, Song WC, Koh KS, et al.: Topography of the masseter muscle in 
relation to treatment with botulinum toxin type A. Oral Surg Oral Med Oral Pathol Oral Radiol 
Endod 110(2): 167-171, 2010.) 
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3. T-Scan analysis 
 
Also, all the patients were examed through T-scan occlusal analysis system(T-scan III, Yours 
Dental Co., Korea) before and 4, 8, 12, 24 weeks after injection. This T-scan system is 
comprised of Microsoft Windows-based software, the associated hardware, and patented paper-
thin disposable sensors(Montgomery et al., 2011).(Fig.2) The information provided on T-Scan 
movies is listed in Table 1. 
The sensor consists of two layer of mylar(reinforced polyester film) laminated pressure 
sensitive ink grid. The film is covered by a silver thread grid, the intersectioning points of 
which are bathed by conductive ink. When a patient closes firmly on the sensor, the resultant 
reduction on electric resistance will be converted to an 8-bit digital values and translated into 
an image on the screen.(Kerstein, 2004) 
The patient was seated in an upright position with because supine position can alter contact 
position. (Makofsky et al., 1991) The T-SCAN III sensor and sensor support assembly were 
inserted intraorally and positioned correctly. Then T-Scan force-movie mode is activated 
manually by pushing the button on the handle. The patients were instructed to bite in the 
habitual intercuspal position, and then made excursive movements which were not guided by 
the investigator. The right and left excursions were recorded separately. Between the records, 
patient had few minutes of resting time. All these procedures were repeated three times and we 
used third record when analyzing the data because when the patient bite the record sensor in 
fist time, it may not reflect the wonted chewing pattern due to unfamiliarity.  
The disclusion time is defined as a time, in seconds, required to disclude the working and 
nonworking molar interferences and non-working premolar interferences from the habitual 
centric closure position to the completion of a mandibular excursion and the occlusion time 
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defined as the time from the first contact of teeth to the maximal intercuspation, and the 
occlusal contact area. (Kerstein and Wright, 1991) 
In this study, we analyzed about the distribution of forces between the left and the right side , 
the distribution of forces between the front and the back side in clenching and the change of 
occlusion time and disclusion time after botulinum toxin type A injection.(Fig. 2.,3.) 
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Figure 2. T-Scan appliance 
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Table 1. The information provided on T-Scan movies 
 
The distribution of forces (as percentages) around the arch 
The timing of the forces – early or late 
The presence of interference during closure 
The balance of forces left to right and/or anterior to posterior at any point during closure 
The effectiveness of guidance patterns that provide somatosensory muscle control 
Evidence of muscle balance or imbalance during function 
Evidence of abnormal dental forces secondary to injury, pain, or inflammation 
Presence and timing of forces that are above or below the average for this patient 
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Figure 2. Balance of clenching force in a T-Scan movie 
Left: divided into two parts: left and right sides 
Right: divided into four parts labeled in clockwise direction : anterior left, anterior right, 
posterior right, posterior left 
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Figure 3. the upper diagram: Occlusion time, the lower diagram: disclusion time  
In the upper diagram, A1 is the point the teeth start to occlude, B1 is the point the dentition is 
fully occluded, and the difference of A1 and B1 is occlusion time, marked as OT. 
In the lower diagram, C1 is the point lateral movement starts, D1 is the point the dentition is 
fully separated and the difference is disclusion time, marked as DT.  
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4. Statistical analysis 
 
Linear mixed models for longitudinal data was carried out to analysis the data in process of 
time. The interaction between times and groups was evaluated by compound symmetry 
covariance structure or banded toeplitz or autoregressive covariance structure. A Bonferroni’s 
correction was used for post hoc analysis. A p–value of < 0.01 was considered statistically 
significant. All statistical analyses were performed using SAS®  Version 9.2 Windows Statistics 
Program (SAS Institute Inc., Cary, NC, USA). 
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III. RESULTS 
 
1. Changes in the distribution of forces 
 
A significant change in force balance was found between the right and left sides over time 
(i.e., preinjection and 4, 8, 12, and 24 weeks post-BTX-A injection) and at each measurement 
time point (p<0.0001). The difference between the two sides decreased with the time 
postinjection, reaching a minimum at 12 weeks (Figure 4). These findings reflect the well-
established time course of the actions of BTX-A(Aoki et al., 2006). In other words, according 
to this result, the left and right clenching force becomes more balanced with the increasing 
effect of botulinum toxin injection.  
Comparison of the force balance between the anterior and posterior occlusions revealed no 
significant difference at any of the time points (i.e., preinjection and 4, 8, 12, and 24 weeks 
postinjection; p>0.01 for all). Furthermore, comparison of the preinjection force balance with 
those measured at 4, 8, 12, and 24 weeks postinjection revealed no significant difference at any 
time point (p>0.05 for all; Table 2). In other words, there is no correlation between the balance 
of anterior and posterior masticatory force and the increasing effect of botulinum toxin 
injection. 
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Figure 4. Force distribution on right and left sides before BTX-A injection (left) and 12 weeks 
thereafter (right) 
In the left figure, before botulinum toxin injection the distribution of the left and right force 
was uneven, 72.1% and 27.9%. 12 weeks post injection, the right figure, the distribution 
evened as left 58.1% and right 41 .9%.  
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Table 2. Changes in the force distribution (%; mean±SD) after injection of BTX-A (n=15) 
 Preinjection 
After 4 
weeks 
After 8 
weeks 
After 12 
weeks 
After 24 
weeks 
Difference between left and right sides (%) 25.5±10.1 15.7±10.3* 11.9±6.0* 7.1±5.6* 16.4±11.4* 
Difference between anterior and posterior (%) 91.0±7.5 90.7±10.1 88.2±12.8 87.6±10.5 87.8±8.7 
*p<0.01 (compared to preinjection)       
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Table 3. Change in occlusion and disclusion times (in seconds) with time after BTX-A injection (n=15) 
 Preinjection 
After 4 
weeks 
After 8 
weeks 
After 12 
weeks 
After 24 
weeks 
Occlusion time 0.32±0.26 0.39±0.51 0.22±0.11 0.20±0.10 0.25±0.10 
Disclusion time (right) 1.52±1.32 2.54±2.17 2.01±1.82 2.69±2.35 1.82±1.79 
Disclusion time (left) 1.30±1.53 1.66±1.94 2.63±2.24 3.24±2.38 3.05±2.30 
*p<0.01 (compared to preinjection)      
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2. Changes in occlusion and disclusion times 
 
The occlusion and disclusion times (right and left sides) did not differ significantly with time 
after BTX-A injection (p>0.01; Table 3). 
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IV. DISCUSSION 
 
Benign masseter hypertrophy is a relatively uncommon condition that can occur unilaterally 
or bilaterally. Unilateral or bilateral hypertrophy of the masseter muscle is characterized by an 
increase in the volume of the muscle mass. This condition is benign, asymptomatic, and must 
be differentiated from parotid gland disease odontogenic problems, and rare neoplasms of 
muscular tissue. The reasons why patients request a medical consultation are predominantly 
related to aesthetics, especially if the hypertrophy is unilateral due to a noticeable asymmetry 
of the lower third of the face. (Addante, 1994; Rispoli et al., 2008). This study was intended for 
the patients who complained only about masseter hypertrophy, and not other symptoms. 
Botulinum toxin is a potent biological toxin produced by Clostridium botulinum(Simpson, 
1981). And it is a pre-synaptic neurotoxin which causes dose-dependent weakness or 
paralysis in skeletal muscle by blocking the calcium-mediated release of acetylcholine from 
motor nerve endings(Drachman, 1964), (Melling et al., 1988). Botulinum toxin type A, one 
of seven subtypes, is a dichain protein consisting of a light chain (50 kD) linked to a heavy 
chain (100 kD) by a disulfide bond(Lang, 2002). This functionally denervates the affected 
portions of the muscle. The primary effect is on α-motor neuron function but may also affect 
the γ motor neurons in the muscle spindles(Filippi et al., 1993). Local paralysis is reversed 
chiefly by neural sprouting with re-innervation of the muscle(Holds et al., 1990). Long-term 
reduction of α-, γ-, and Ia-neuronal activity may have indirect effects on the central nervous 
system. This was demonstrated when Moreno-Lopez et al. showed that single injections of 
botulinum toxin type A into the lateral rectus muscle of cats caused inhibition of abduction, 
altered electro myographic signals of the contralateral ocular muscles, and a disruption of 
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abducens motor neuron discharge patterns that lasted longer than 2 months(Moreno-Lopez et 
al., 1994). Botulinum toxin type A may also act directly or indirectly on nociceptors that 
affect transmission of sensory signals through α−δ and C-γ fibers, and impact detection of 
sensory signals through mechanoreceptors and chemonociceptors(Priori et al., 1995). These 
reports may explain the changes of the distribution in clenching forces after botulinum toxin 
type A injection in our study. We think that redistribution of clenching force after botulinum 
toxin type A injection is due to the changes of chewing pattern in central nervous system 
level as well as atrophy and weakness of peripheral muscle resion. But, it will be in need of 
more detailed study about the exact mechanism of chewing pattern change occured in central 
nerves system.  
As above, with increasing medicinal effects of botulinum toxin type A, there is decline in 
clenching force difference of left and right side after botulinum toxin type A injection. But 
there was no significant change of occlusal time and disclusion time after botulinum toxin type 
A injection. Decline in difference of clenching force is because of that botulinum toxin can 
influence on transmission of sensory signal by α−δ and C-γ fiber directly or indirectly as 
mentioned above. Our results seem to be able to support this opinion. The duration of 
occlusion time and disclusion time are determined by interference of teeth but botulinum toxin 
cannot influence on interference of teeth so there might not be significant change in occlusion 
time and disclusion time after botulinum toxin type A injection. Also, because the contact 
between upper and lower anterior tooth is much more light than contact between upper and 
lower posterior tooth in normal occlusion, botulinum toxin cannot change of anterior teeth 
contact so there was no significant difference between front and back side balance according to 
time. But when all the subjects have full-contact arch, it may be possible to change of 
difference between front and back side balance after injection. 
21 
There was several limitations in this study. First, actually some patients were acclimatized to 
T-scan examination compared with the first time so velocity of clenching or lateral movement 
was quickened as following the examination repeatedly. This phenomenon seems to have low 
probability on distribution of clenching force but have slight effect on occlusion and disclusion 
time. In spite of this limitation, we used the third data instead of mean data of three measured 
values. Because we thought that first and second data was inaccurate.  
Second, we have no control group. So we could not consider about any placebo effect. If 
later similar study is performed, we recommend to supplement  these limitations. 
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V. CONCLUSION  
 
Fifteen patients were examined using the T-Scan system before and after BTX-A injection 
into the masseter muscles. A decline in the difference in the clenching force between the left 
and right sides was found with increasing time (and hence increasing medicinal effect) up to 
12 weeks following BTX-A injection. 
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ABSTRACT (in Korean) 
 
전산화 교합 분석 시스템을 이용하여 분석한 
보툴리눔 독소 주사 전후의 교합력 분포와 시간의 변화 
 
<지도 안 형 준 교수> 
연세대학교 대학원 치의학과 
송 지 희 
 
 
보툴리눔 독소가 주사된 근육에 진통효과 및 과활성을 줄이는 효과를 가지고 
있다는 것은 종종 관찰되어왔다. 그러나 본 진료실에서 보툴리눔 독소 주사를 
시행하기 전에 한쪽으로 씹는 습관이 있었으나 주사후에는 양쪽의 씹는 힘이 
비슷해졌다고 주장하는 몇몇의 환자들이 있었다. 하지만 보툴리눔 독소 주사의 
이러한 효과에 대한 연구는 그동안 없었다. 그리하여 우리는 보툴리눔 독소와 
저작력의 분포와의 관계에 대한 연구를 시행하였다.  
 이 연구의 목적은 보툴리눔 독소를 양측 교근에 주사한 후 저작력의 분포와 
패턴을 분석하는 것이다. 본 연구의 가설은 보툴리눔 독소 주사 후에 좌, 우측의 
교합력의 차이가 줄어들 것이라는 것이다.  
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주관적인 교근 비대를 호소하는 15명의 환자가 본 연구에 등록 되었고 보툴리눔 
독소 25U(총 50U)을 양측 교근의 하방 1/3 의 가운데에서 약 1cm의 간격을 
두고 지정한 두개의 자입점에 나누어 주사하였다. 모든 환자들은 주사전, 주사후 
4,8,12,24주에 T-Scan 교합분석시스템을 이용하여 검사를 받았다.  
 연구 결과 좌우측 교합력의 분포에서 유의한 변화가 관찰되었는데 주사후 
시간이 지날수록 좌우측 교합력의 차이는 감소하였으며 주사후 12주에서 최소치를 
보였다. 전후방 교합력의 차이에서는 유의한 변화가 관찰되지 않았으며 occlusion 
time 과 disclusion time 에서도 유의한 변화는 없었다.  
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